The state of the art in the treatment of severe aplastic anemia: immunotherapy and hematopoietic cell transplantation in children and adults.
Piekarska A, Pawelec K, Szmigielska-Kapłon A, Ussowicz M.
Front Immunol. 2024 Apr 5;15:1378432. doi: 10.3389/fimmu.2024.1378432. eCollection 2024.
Congenital neutropenia syndromes.
Boztug K, Welte K, Zeidler C, Klein C.
Immunol Allergy Clin North Am. 2008 May;28(2):259-75, vii-viii. doi: 10.1016/j.iac.2008.01.007.
WAS-Related Disorders.
Chandra S, Nagaraj CB, Sun M, Chandrakasan S, Zhang K.
2004 Sep 30 [updated 2024 Aug 15]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
Congenital X-linked neutropenia with myelodysplasia and somatic tetraploidy due to a germline mutation in SEPT6.
Renella R, Gagne K, Beauchamp E, Fogel J, Perlov A, Sola M, Schlaeger T, Hofmann I, Shimamura A, Ebert BL, Schmitz-Abe K, Markianos K, Murphy K, Sun L, Rockowitz S, Sliz P, Campagna DR, Springer TA, Bahl C, Agarwal S, Fleming MD, Williams DA.
Am J Hematol. 2022 Jan 1;97(1):18-29. doi: 10.1002/ajh.26382. Epub 2021 Nov 3.
Etiologic factors in congenital displacement of the hip and myelodysplasia.
Wilkinson JA.
Clin Orthop Relat Res. 1992 Aug;(281):75-83.
Severe congenital neutropenia.
Welte K, Zeidler C, Dale DC.
Semin Hematol. 2006 Jul;43(3):189-95. doi: 10.1053/j.seminhematol.2006.04.004.
Congenital erythropoietic porphyria associated with myelodysplasia presenting in a 72-year-old man: report of a case and review of the literature.
Kontos AP, Ozog D, Bichakjian C, Lim HW.
Br J Dermatol. 2003 Jan;148(1):160-4. doi: 10.1046/j.1365-2133.2003.05040.x.
Hereditary myeloid malignancies.
Rafei H, DiNardo CD.
Best Pract Res Clin Haematol. 2019 Jun;32(2):163-176. doi: 10.1016/j.beha.2019.05.001. Epub 2019 May 3.
ELANE-Related Neutropenia.
Dale DC, Makaryan V.
2002 Jun 17 [updated 2018 Aug 23]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
Comparison of a restrictive versus liberal red cell transfusion policy for patients with myelodysplasia, aplastic anaemia, and other congenital bone marrow failure disorders.
Gu Y, Estcourt LJ, Doree C, Hopewell S, Vyas P.
Cochrane Database Syst Rev. 2015 Oct 5;2015(10):CD011577. doi: 10.1002/14651858.CD011577.pub2.
